Since the pandemic began, research on COVID-19 has moved at a breakneck pace. Indications of COVID-19 infection as a systemic illness emerged relatively early, with accumulating evidence showing a wide range of effects on almost every organ system.
Already, a number of published reviews have described neurologic complications of COVID-19. As more data become available, knowledge and understanding of neurologic findings in COVID-19 may change. However, current comparison to similar infections like Middle East Respiratory Syndrome (MERS), influenza H1N1, and the novel severe acute respiratory syndrome coronavirus 1 (SARS-CoV1) suggests the need for early recognition of neurologic complications, as well as monitoring for neurologic sequelae over time in survivors.
